EXCLUSIVE: New On NASDAQ Deck, Revelation Bio’s COVID-19 Antiviral Shows Encouraging Preclinical Action
Revelation Biosciences Inc (NASDAQ: REVB) says that it observed a significant decrease in viral load with the prophylactic treatment of REVTx-99 in models of COVID-19 infection.